# Tirzepatide for Obesity Treatment and Diabetes Prevention

Article · Ania M. Jastreboff, Carel Wynand le Roux, Adam Stefański, Louis J. Aronne, Bruno Halpern, Sean Wharton, John P.H. Wilding, Leigh Perreault, Shuyu Zhang, Ramakrishna Battula, Mathijs C. M. Bunck, Nadia N. Ahmad, Irina Jouravskaya

- Archive id: doi:10.1056/nejmoa2410819
- Published: 2024-11-13
- Venue: New England Journal of Medicine
- DOI: https://doi.org/10.1056/nejmoa2410819
- PMID: 39536238
- Citations: 458
- Source URL: https://doi.org/10.1056/nejmoa2410819
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

Cited in dossiers:
- [GLP-1 & Incretin Therapies: State of the Field (October 2026)](https://space-kitty.com/dossiers/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.